Cargando…
Serum Creatinine as a Potential Biomarker of Skeletal Muscle Atrophy in Non-small Cell Lung Cancer Patients
Objectives: Identifying simple biomarkers to determine muscle atrophy in non-small-cell lung cancer (NSCLC) patients remains a critical research gap. Since creatinine is mainly a product from intramuscular creatine metabolism, we tested the hypothesis that low serum creatinine levels would be associ...
Autores principales: | das Neves, Willian, Alves, Christiano R. R., de Souza Borges, Ana Paula, de Castro, Gilberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072336/ https://www.ncbi.nlm.nih.gov/pubmed/33912068 http://dx.doi.org/10.3389/fphys.2021.625417 |
Ejemplares similares
-
Ubiquitin-proteasome pathway in skeletal muscle atrophy
por: Pang, XiangSheng, et al.
Publicado: (2023) -
Atrophy Resistant vs. Atrophy Susceptible Skeletal Muscles: “aRaS” as a Novel Experimental Paradigm to Study the Mechanisms of Human Disuse Atrophy
por: Bass, Joseph J., et al.
Publicado: (2021) -
Role of E2-Ub-conjugating enzymes during skeletal muscle atrophy
por: Polge, Cecile, et al.
Publicado: (2015) -
Integrating Mechanisms of Exacerbated Atrophy and Other Adverse Skeletal Muscle Impact in COPD
por: Taivassalo, Tanja, et al.
Publicado: (2022) -
Leucine minimizes denervation-induced skeletal muscle atrophy of rats through akt/mtor signaling pathways
por: Ribeiro, Carolina B., et al.
Publicado: (2015)